Literature DB >> 19684062

Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.

Juliet E Jennings1, Marianthi Georgitsi, Ian Holdaway, Adrian F Daly, Maria Tichomirowa, Albert Beckers, Lauri A Aaltonen, Auli Karhu, Fergus J Cameron.   

Abstract

OBJECTIVE: Mutations in the aryl hydrocarbon receptor-interacting protein (AIP) were recently shown to confer a pituitary adenoma predisposition in patients with familial isolated pituitary adenomas (FIPA). We report a large Samoan FIPA kindred from Australia/New Zealand with an R271W mutation that was associated with aggressive pituitary tumors. DESIGN AND METHODS: Case series with germline screening of AIP and haplotype analyses among R271W families.
RESULTS: This previously unreported kindred consisted of three affected individuals that either presented with or had first symptoms of a pituitary macroadenoma in late childhood or adolescence. The index case, a 15-year-old male with incipient gigantism and his maternal aunt, had somatotropinomas, and the maternal uncle of the index case had a prolactinoma. All tumors were large (15, 40, and 60 mm maximum diameter) and two required transcranial surgery and radiotherapy. All three affected subjects and ten other unaffected relatives were found to be positive for a germline R271W AIP mutation. Comparison of the single nucleotide polymorphism patterns among this family and two previously reported European FIPA families with the same R271W mutation demonstrated no common ancestry.
CONCLUSIONS: This kindred exemplifies the aggressive features of pituitary adenomas associated with AIP mutations, while genetic analyses among three R271W FIPA families indicate that R271W represents a mutational hotspot that should be studied further in functional studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19684062     DOI: 10.1530/EJE-09-0406

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  13 in total

1.  The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?

Authors:  G Occhi; M L Jaffrain-Rea; G Trivellin; N Albiger; F Ceccato; E De Menis; M Angelini; S Ferasin; A Beckers; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2010-03-30       Impact factor: 4.256

2.  Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.

Authors:  Liliya Rostomyan; Adrian F Daly; Patrick Petrossians; Emil Nachev; Anurag R Lila; Anne-Lise Lecoq; Beatriz Lecumberri; Giampaolo Trivellin; Roberto Salvatori; Andreas G Moraitis; Ian Holdaway; Dianne J Kranenburg-van Klaveren; Maria Chiara Zatelli; Nuria Palacios; Cecile Nozieres; Margaret Zacharin; Tapani Ebeling; Marja Ojaniemi; Liudmila Rozhinskaya; Elisa Verrua; Marie-Lise Jaffrain-Rea; Silvia Filipponi; Daria Gusakova; Vyacheslav Pronin; Jerome Bertherat; Zhanna Belaya; Irena Ilovayskaya; Mona Sahnoun-Fathallah; Caroline Sievers; Gunter K Stalla; Emilie Castermans; Jean-Hubert Caberg; Ekaterina Sorkina; Renata Simona Auriemma; Sachin Mittal; Maria Kareva; Philippe A Lysy; Philippe Emy; Ernesto De Menis; Catherine S Choong; Giovanna Mantovani; Vincent Bours; Wouter De Herder; Thierry Brue; Anne Barlier; Sebastian J C M M Neggers; Sabina Zacharieva; Philippe Chanson; Nalini Samir Shah; Constantine A Stratakis; Luciana A Naves; Albert Beckers
Journal:  Endocr Relat Cancer       Date:  2015-07-17       Impact factor: 5.678

Review 3.  Familial isolated pituitary adenomas: from genetics to therapy.

Authors:  Federica Guaraldi; Roberto Salvatori
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

4.  Familial isolated pituitary adenoma caused by a Aip gene mutation not described before in a family context.

Authors:  J A García-Arnés; I González-Molero; J Oriola; N Mazuecos; R Luque; J Castaño; M A Arraez
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

Review 5.  Genetic mutations in sporadic pituitary adenomas--what to screen for?

Authors:  Anne-Lise Lecoq; Peter Kamenický; Anne Guiochon-Mantel; Philippe Chanson
Journal:  Nat Rev Endocrinol       Date:  2014-10-28       Impact factor: 43.330

Review 6.  Familial isolated pituitary adenomas: an emerging clinical entity.

Authors:  F Martucci; G Trivellin; M Korbonits
Journal:  J Endocrinol Invest       Date:  2012-12       Impact factor: 4.256

Review 7.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

8.  SNPs in the aryl hydrocarbon receptor-interacting protein gene associated with sporadic non-functioning pituitary adenoma.

Authors:  Yeshuai Hu; Jun Yang; Yongkai Chang; Shunchang Ma; Jianfa Qi
Journal:  Exp Ther Med       Date:  2016-01-18       Impact factor: 2.447

9.  Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome.

Authors:  Luciana A Naves; Adrian F Daly; Luiz Augusto Dias; Bo Yuan; Juliano Coelho Oliveira Zakir; Gustavo Barcellos Barra; Leonor Palmeira; Chiara Villa; Giampaolo Trivellin; Armindo Jreige Júnior; Florêncio Figueiredo Cavalcante Neto; Pengfei Liu; Natalia S Pellegata; Constantine A Stratakis; James R Lupski; Albert Beckers
Journal:  Endocrine       Date:  2015-11-25       Impact factor: 3.633

10.  Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.

Authors:  Susana Igreja; Harvinder S Chahal; Peter King; Graeme B Bolger; Umasuthan Srirangalingam; Leonardo Guasti; J Paul Chapple; Giampaolo Trivellin; Maria Gueorguiev; Katie Guegan; Karen Stals; Bernard Khoo; Ajith V Kumar; Sian Ellard; Ashley B Grossman; Márta Korbonits
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.